Peramivir Trihydrate — CAS 1041434-82-5

Peramivir Trihydrate is the trihydrate crystalline form of Peramivir, the IV neuraminidase inhibitor antiviral. Mediocon Inc manufactures this high-purity API at its GMP-certified facility in Aurangabad, Maharashtra, India. The trihydrate form is the commercially used pharmaceutical-grade form in approved Rapiacta and Peramiflu intravenous formulations. It offers superior stability characteristics, consistent crystalline morphology, and defined water content essential for parenteral pharmaceutical manufacturing.

• IV influenza A and B treatment — the approved pharmaceutical salt form
• Parenteral antiviral formulation manufacturing
• Severe influenza in ICU and hospitalized patients
• Antiviral preparedness programs requiring injectable dosage forms

• GMP Certified manufacturing facility in Aurangabad, Maharashtra, India
• Full pharmacopoeial compliance: IP / BP / EP / USP standards
• Complete documentation: Certificate of Analysis (CoA), MSDS, Certificate of Origin
• Stringent in-process quality control at every manufacturing stage
• HPLC purity testing and spectroscopic identification (IR, NMR)
• Cold-chain and controlled-environment storage facilities available
• Exported to 40+ countries with full regulatory support